TRILC logo

Turk Ilac Ve Serum Sanayi Anonim Sirketi Stock Price

IBSE:TRILC Community·₺2.5b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 2 Fair Values set on narratives written by author

TRILC Share Price Performance

₺15.71
-7.15 (-31.28%)
₺15.71
-7.15 (-31.28%)
Price ₺15.71

TRILC Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Good value with adequate balance sheet.

2 Risks
1 Reward

Turk Ilac Ve Serum Sanayi Anonim Sirketi Key Details

₺4.5b

Revenue

₺3.0b

Cost of Revenue

₺1.6b

Gross Profit

₺2.2b

Other Expenses

-₺622.6m

Earnings

Last Reported Earnings
Dec 31, 2025
Next Reporting Earnings
n/a
-3.85
34.67%
-13.72%
150.0%
View Full Analysis

About TRILC

Founded
2010
Employees
709
CEO
Yunus Battal
WebsiteView website
www.turkilac.com.tr

Turk Ilac Ve Serum Sanayi Anonim Sirketi produces and sells human tablets, capsules, ampoules, vials, ointments-creams, intravenous serums, parenteral solutions, nutritional solutions, amino acids, and other chemicals in Turkey. It also offers bulb, biological, and serum products, as well as medical devices. Turk Ilac Ve Serum Sanayi Anonim Sirketi was founded in 2010 and is headquartered in Ankara, Turkey.

Recent TRILC News & Updates

Recent updates

No updates